Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K/AKT and MAPK pathways

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wang, Ziliang ^a   Hou, Jing ^a   Lu, Lili ^b   Qi, Zihao ^a   Sun, Jianmin ^a   Gao, Wen ^a   Meng, Jiao ^a   Wang, Yan ^a   Sun, Huizhen ^a   Gu, Hongyu ^a   Xin, Yuhu ^a   Guo, Xiaomao ^a   Yang, Gong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN P110; PROTEIN P110 ALPHA; PROTEIN P85; PROTEIN P85 ALPHA; RIBOSOME PROTEIN; SMALL RIBOSOMAL PROTEIN SUBUNIT S7; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARIAN TUMORIGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEINS;

EID: 84893023460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079117     Document Type: Article

References (29)

1. Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M et al. (2012) Ovarian Cancer, Version 3.2012. J Natl Compr Canc Netw 10: 1339-1349.
2. Seong KM, Jung SO, Kim HD, Kim HJ, Jung YJ et al. (2012) Yeast ribosomal protein S3 possesses a beta-lyase activity on damaged DNA. FEBS Lett 586: 356-361. doi:10.1016/j.febslet.2011.12.030. PubMed: 22245673.
3. Kobayashi Y, Kawakami K, Ohbayashi M, Kohyama N, Yamamoto T (2010) Ribosomal protein L3 mediated the transport of digoxin in Xenopus laevis oocyte. J Toxicol Sci 35: 827-834. doi:10.2131/jts.35.827. PubMed: 21139332.
4. Wu Q, Gou Y, Wang Q, Jin H, Cui L et al. (2011) Down-regulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PLOS ONE 6: e26401. doi:10.1371/journal.pone.0026401. PubMed: 22043320.
5. Kobayashi T, Sasaki Y, Oshima Y, Yamamoto H, Mita H et al. (2006) Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. Int J Mol Med 18: 161-170. PubMed: 16786168.
6. Kondoh N, Schweinfest CW, Henderson KW, Papas TS (1992) Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52: 791-796. PubMed: 1339304.
7. Li C, Ge M, Yin Y, Luo M, Chen D (2012) Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells. Mol Cell Biochem 370: 127-139. doi:10.1007/s11010-012-1404-x. PubMed: 22868929.
8. Bee A, Brewer D, Beesley C, Dodson A, Forootan S et al. (2011) siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer. PLOS ONE 6: e22672. doi:10.1371/journal.pone.0022672. PubMed: 21799931.
9. Gou Y, Shi Y, Zhang Y, Nie Y, Wang J et al. (2010) Ribosomal protein L6 promotes growth and cell cycle progression through up-regulating cyclin E in gastric cancer cells. Biochem Biophys Res Commun 393: 788-793. doi:10.1016/j.bbrc.2010.02.083. PubMed: 20171175.
10. Wang Q, Yang C, Zhou J, Wang X, Wu M et al. (2001) Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene 263: 205-209. doi:10.1016/S0378- 1119(00)00570-9. PubMed: 11223259. (Pubitemid 32167070)
11. Wu LM, Wang SY, Wang SX, Huang YM, Li JG (2010) [Proliferation promotion and apoptotic inhibition effects of ribosomal protein RPL36A small interference RNA on U937 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 344-349. PubMed: 20416165.
12. Wu CT, Lin TY, Hsu HY, Sheu F, Ho CM et al. (2011) Ling Zhi-8 mediates p53-dependent growth arrest of lung cancer cells proliferation via the ribosomal protein S7-MDM2-p53 pathway. Carcinogenesis 32: 1890-1896. doi:10.1093/carcin/ bgr221. PubMed: 21983128.
13. Duan J, Ba Q, Wang Z, Hao M, Li X et al. (2011) Knockdown of ribosomal protein S7 causes developmental abnormalities via p53 dependent and independent pathways in zebrafish. Int J Biochem Cell Biol 43: 1218-1227. doi:10.1016/j.biocel.2011.04.015. PubMed: 21550419.
14. Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J et al. (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 35: 316-326. doi:10.1016/j.molcel.2009.07.014. PubMed: 19683495.
15. Chen D, Zhang Z, Li M, Wang W, Li Y et al. (2007) Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26: 5029-5037. doi:10.1038/sj.onc.1210327. PubMed: 17310983. (Pubitemid 47206956)
16. Auersperg N, Siemens CH, Myrdal SE (1984) Human ovarian surface epithelium in primary culture. In Vitro 20: 743-755. doi:10.1007/BF02618290. PubMed: 6083974. (Pubitemid 15171896)
17. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K et al. (2004) A genetically defined model for human ovarian cancer. Cancer Res 64: 1655-1663. doi:10.1158/0008-5472.CAN-03-3380. PubMed: 14996724. (Pubitemid 38428686)
18. Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc;1(3): 1458-1461. doi:10.1038/nprot.2006. 238. PubMed: 17406435.
19. Yang G, Chang B, Yang F, Guo X, Cai KQ et al. (2010) Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16: 3171-3181. doi:10.1158/1078-0432.CCR- 09-3171. PubMed: 20423983.
20. Yang G, Rosen DG, Zhang Z, Bast RC Jr., Mills GB et al. (2006) The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A 103: 16472-16477. doi:10.1073/pnas.0605752103. PubMed: 17060621. (Pubitemid 44715220)
21. Yang G, Rosen DG, Liu G, Yang F, Guo X et al. (2010) CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res 16: 3875-3886. doi:10.1158/1078-0432. CCR-10-0483. PubMed: 20505188.
22. Yang G, Thompson JA, Fang B, Liu J (2003) Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer. Oncogene 22: 5694-5701. doi:10.1038/sj.onc.1206858. PubMed: 12944918. (Pubitemid 37102706)
23. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M et al. (2010) Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 102: 812-827. doi:10.1093/jnci/djq127. PubMed: 20484106.
24. Yang G, Xiao X, Rosen DG, Cheng X, Wu X et al. (2011) The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer. Clin Cancer Res 17: 2181-2194. doi:10.1158/1078-0432.CCR-10-3265. PubMed: 21339307.
25. Lindström MS, Nistér M (2010) Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLOS ONE 5: e9578. doi:10.1371/journal.pone. 0009578. PubMed: 20221446.
26. Guo X, Shi Y, Gou Y, Li J, Han S et al. (2011) Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1). J Cell Mol Med 15: 296-306. doi:10.1111/j.1582-4934.2009.00969.x. PubMed: 19912438.
27. Bee A, Ke Y, Forootan S, Lin K, Beesley C et al. (2006) Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clin Cancer Res 12: 2061-2065. doi:10.1158/1078-0432.CCR-05-2445. PubMed: 16609016.
28. Llanos S, Serrano M (2010) Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle 9: 4005-4012. doi:10.4161/cc.9.19.13299. PubMed: 20935493.
29. Chien CC, Tu TC, Huang CJ, Yang SH, Lee CL (2012) Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer. ISRN. Gastroenterologist 2012: 394545.